Physician profile
William O Ntim
NPI 1043290794
$7,440.88
in general payments reported to CMS, 2019-2025
30 companies · $2,262 in 2025
The $2,262 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $315 · 2021: $763 · 2022: $771 · 2023: $1,319 · 2024: $1,704 · 2025: $2,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,131 · Travel and Lodging: $1,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,130.78 |
| Travel and Lodging | $1,153.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,477.15 | 2021-2025 | Triclip |
| Novartis Pharmaceuticals Corporation | $929.42 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $871.13 | 2021-2024 | Xarelto |
| Amgen INC. | $603.15 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $499.84 | 2019-2025 | Watchman Flx, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $458.10 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $420.15 | 2020-2025 | Farxiga, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $416.90 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $408.13 | 2023-2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $207.02 | 2022-2025 | |
| Novo Nordisk INC | $136.87 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Scpharmaceuticals INC. | $130.84 | 2023-2024 | |
| Heartflow, INC. | $114.55 | 2022-2025 | Ffrct |
| Kiniksa Pharmaceuticals International, Plc | $106.23 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.02 | 2021-2025 | Jardiance |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $61.51 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $56.37 | 2023 | Arcalyst |
| Irhythm Technologies, INC. | $46.76 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Stryker Corporation | $46.59 | 2025 | Flowtriever |
| Merck Sharp & Dohme LLC | $45.81 | 2023-2024 | Verquvo |
| Medtronic, INC. | $45.66 | 2024 | Symplicity G3 |
| Ge Healthcare | $44.23 | 2019 | |
| Cvrx, INC. | $43.18 | 2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $42.12 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $30.39 | 2025 | |
| Gilead Sciences, INC. | $26.00 | 2022 | |
| Edwards Lifesciences Corporation | $22.23 | 2020 | |
| Medtronic Vascular, INC. | $21.65 | 2020 | |
| Pfizer INC. | $21.48 | 2025 | |
| Csl Behring | $19.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ntim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.